COVI-Preg, a structured data collection tool available to any facility assessing pregnant patients for SARS-CoV-2 infection

28 Apr, 2020

Emerging infectious diseases require a global approach and adaptive tools to allow for rapid and comprehensive characterisation of the risks associated with the disease, particularly in pregnancy. That is why some scientists have adapted a Zika Virus international web registry, to acquire large cohorts and allow accurate risk estimations, and therefore a global perspective for scientists and clinicians involved in the care of pregnant patients during the pandemic. 

Today, with increased mobility and considerable migration, we have to use the modern tool of worldwide and immediate communication to trigger knowledge sharing and prepare for rapid assessment of existing and future emergent pathogens. This registry and its associated international network will be organised to be rapidly adaptable to any other emerging infectious agent in the future. The feasibility of this global responsive and customisable structure for future emergent pathogens is supported by the strong platform of well established collaborations with 198 antenatal clinics from 23 countries in Africa, Asia, Europe, Oceania, and the Americas (figure). This structure will allow for the creation of a large dataset capturing global information in an attainable and realistic manner, with affordable costs and an acceptable timeframe.

To acces the new Covid-Preg website, click here.

Click here for reference.